Embla Medical hf
CSE:EMBLA

Watchlist Manager
Embla Medical hf Logo
Embla Medical hf
CSE:EMBLA
Watchlist
Price: 32.8 DKK -1.5% Market Closed
Market Cap: 14.1B DKK
Section:
 

Relative Value

The Relative Value of one EMBLA stock under the Base Case scenario is 47.83 DKK. Compared to the current market price of 32.8 DKK, Embla Medical hf is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EMBLA Relative Value
Base Case
47.83 DKK
Undervaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.5
P/S
P/S
Price to Sales
2.5
vs History
57
vs Industry
47
Median 3Y
2.5
Median 5Y
2.6
Industry
2.3
Forward
2.3
More Details
28.7
P/E
P/E
Price to Earnings
28.7
vs History
90
vs Industry
22
Median 3Y
31.4
Median 5Y
33.8
Industry
22.4
Forward
25.7
More Details
17.8
P/OCF
P/OCF
Price to OCF
17.8
vs History
87
vs Industry
25
Median 3Y
19.5
Median 5Y
22
Industry
14.4
More Details
111.4
P/FCFE
P/FCFE
Price to FCFE
111.4
vs History
22
vs Industry
19
Median 3Y
51.8
Median 5Y
51.8
Industry
21.7
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
77
vs Industry
37
Median 3Y
2.7
Median 5Y
2.8
Industry
2.2
More Details
2.9
EV/S
EV/S
Enterprise Value to Sales
2.9
vs History
53
vs Industry
42
Median 3Y
2.9
Median 5Y
3.1
Industry
2.5
Forward
2.7
More Details
4.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.7
vs History
60
vs Industry
50
Median 3Y
4.7
Median 5Y
4.9
Industry
5.1
More Details
14.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.2
vs History
84
vs Industry
27
Median 3Y
15.6
Median 5Y
16.5
Industry
12
Forward
13.5
More Details
21
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21
vs History
85
vs Industry
24
Median 3Y
23.8
Median 5Y
25.6
Industry
16.9
Forward
19.9
More Details
21.1
EV/OCF
EV/OCF
Enterprise Value to OCF
21.1
vs History
87
vs Industry
21
Median 3Y
23.2
Median 5Y
25.2
Industry
14.5
More Details
28.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
28.5
vs History
90
vs Industry
17
Median 3Y
42.1
Median 5Y
43
Industry
18.6
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
73
vs Industry
46
Median 3Y
1.7
Median 5Y
1.8
Industry
1.8
More Details

Multiples Across Competitors

EMBLA Competitors Multiples
Embla Medical hf Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IS
Embla Medical hf
CSE:EMBLA
14B DKK 2.5 28.7 14.2 21
US
Abbott Laboratories
NYSE:ABT
217B USD 5 15.5 19.8 27.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
206.9B USD 21.5 75.3 57.8 70.5
US
Boston Scientific Corp
NYSE:BSX
142.5B USD 7.4 51.1 29.8 40.6
US
Stryker Corp
NYSE:SYK
135.6B USD 5.6 46.1 22.5 27.2
IE
Medtronic PLC
NYSE:MDT
124.7B USD 3.6 26.2 14.7 21.3
DE
Siemens Healthineers AG
XETRA:SHL
49.9B EUR 2.1 23.3 13.2 18.6
US
Becton Dickinson and Co
NYSE:BDX
56B USD 2.6 33.4 12.4 21
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.1B USD 13.2 53.6 38.5 42.6
US
Edwards Lifesciences Corp
NYSE:EW
50.1B USD 8.5 36.6 26.2 28.7
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38B USD 1.9 17.1 12.8 15.5

See Also

Summary
EMBLA intrinsic value, competitors valuation, and company profile.
DCF Valuation
EMBLA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EMBLA stock valuation using valuation multiples.
Wall Street Estimates
EMBLA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EMBLA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 305,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.